Generally, roughly half of women with MMR‐D nonmethylated endometrial cancer can be identified as having Lynch‐like syndrome which refers to individuals whose tumors show MMR deficiency but who are subsequently found not to carry an MMR gene mutation after germline DNA testing and who also show no evidence of MLH1 methylation.27 Here, MLH1 is linked to endometrial cancer.